Actively Recruiting
SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-02-19
200
Participants Needed
2
Research Sites
105 weeks
Total Duration
On this page
Sponsors
F
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Lead Sponsor
A
ASL 1 Avezzano Sulmona L'Aquila
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study focuses on rare brain tumors, which are heterogeneous entities with different morphological, biological, and clinical characteristics. Due to their rarity, many of these tumors fall under the RARECARE definition of rare tumors. The main objective of the study is to standardize care models and pathways for patients with rare brain tumors, using Artificial Intelligence (AI) and Machine Learning (ML) techniques to identify specific predictors of postoperative outcomes. The study includes both retrospective and prospective phases, with the collection of clinical, cognitive, and psychological data at various time points. Patients will undergo an early neuro-cognitive rehabilitation program using the RehaCom software, which will be conducted at home. The goal is to improve the quality of life and care for patients through a multidisciplinary and innovative approach.
CONDITIONS
Official Title
SIMPLIFication of Care Pathways for Patients With Rare Brain Tumors Through Artificial Intelligence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (age 6518 years)
- Both sexes
- Patients with rare brain tumors (incidence <6 cases per 100,000 people/year)
- Candidates for craniotomy for rare brain tumors
- Native Italian speakers for cognitive and psychological evaluation and neuro-cognitive rehabilitation
You will not qualify if you...
- Patients undergoing stereotactic/frameless biopsy
- Patients with psychiatric disorders or on psychotropic medications
- Patients with known cognitive decline not related to the tumor
- Patients admitted on the same day as the surgery
- Patients with severe impairments referred to rehabilitation centers
- Patients without a Windows PC or laptop with Internet connection for neuro-cognitive rehabilitation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milan, PA, Italy, 20133
Actively Recruiting
2
ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila
L’Aquila, Italy, 67100
Not Yet Recruiting
Research Team
G
GIORGIA CAMARDA, Master's degree
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here